InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Seth Sandesh. Director active across 1 company, notably Actinium Pharmaceuticals, Inc.. Aggregated, 4 reports have been logged. History available since 17 August 2022. The latest transaction was filed on 2 September 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
SETH SANDESH is linked to Actinium Pharmaceuticals, Inc., where he holds the role of Chief Executive Officer. The declarant has 4 filings in total, and across the 4 most recent sampled filings the buy and sell amounts are EUR 0, with filings spanning from 2022-08-19 to 2026-09-04. The stated transaction nature is Attribution.